In her new memoir, “The Invisible Kingdom: Reimagining Chronic Illness,” author and journalist Meghan O’Rourke chronicles her odyssey toward a diagnosis after enduring an array of debilitating symptoms for more than a decade. There were headaches, dizziness, brain fog, a rash on her inner arms, among other things.

She writes that she got sick the way Ernest Hemingway said you go broke: “gradually and then suddenly.” As her symptoms worsened throughout her 20s and 30s, she went looking for answers.

“I was really left on my own to try to put the pieces of the puzzle together,” Ms. O’Rourke told the Pittsburgh Post-Gazette in an interview.

In her book, she writes about the Allegheny Health Network’s Autoimmunity Institute, a place she wished existed during her quest. The center, which brings together medical specialists from 15 different fields, opened at West Penn Hospital in 2018. The institute caters to patients like her: people with medical mysteries and those with one or more autoimmune conditions who have gone undiagnosed or untreated for several years. The institute treats complex cases like detective work: poring over patients’ medical history before they come in for their first appointment.

Advertise with us

“When I got acutely sick,” Ms. O’Rourke writes, “ I could only dream of such a scenario! Instead, I laboriously made my many appointments, trundling from doctor to doctor, trying to get them to share information and offer treatments.”

Ms. O’Rourke recalled spending hours a week in New York City’s subway system, traveling to and from various specialists and navigating the health care system. In 2012, at age 36, she finally received a diagnosis: autoimmune thyroiditis, a condition in which the immune system damages the thyroid.

Meghan O’Rourke (David Surowieck)

“There was a certain amount of relief because it meant that the reality I had been living in was not all in my head,” she said. “It restored some sense of trust I have in my own perceptions.”

The book, which came out last month, explores the invisible crisis of autoimmune disease, which affects an estimated 24 million people in the United States — about 7% of the population, according to the National Institutes of Health. The Autoimmune Association, a Michigan-based advocacy nonprofit, says it takes patients an average of five years to get to a diagnosis.

At the Autoimmunity Institute, one of just a few centers like it in the country, health care providers coordinate care for patients instead of letting patients do it on their own. Run by Dr. Joseph Ahearn and Dr. Susan Manzi, rheumatologists who specialize in lupus, the institute offers in-depth appointments during which patients can see more than one specialist at a time. Because most states lack such resources for treating autoimmune disease, patients from 35 states have traveled to the center for treatment in the four years since it opened.

Advertise with us

“When patients leave they often will say, ‘This is the first time someone's actually listened to me in years,’” Dr. Ahearn said.

When the body attacks itself

There are more than 80 autoimmune diseases, and they run the gamut from rheumatoid arthritis, Type 2 diabetes and Crohn’s disease to lupus, Lyme disease and fibromyalgia. Autoimmune disorders are more common among women, occurring at a rate of 2-to-1.

In a healthy person, the immune system acts as the first line of defense against external invaders, such as bacteria, viruses and allergens. But in people with autoimmune disorders, the immune system attacks and destroys healthy tissue by mistake.

“In autoimmunity, the immune system is unregulated,” said Dr. Manzi. “It begins to recognize itself as being foreign to the body and it mounts an attack against itself. Depending on where that attack is targeted, that's the disease that you get.”

Advertise with us

For example, if your immune system targets the thyroid, you could end up with autoimmune thyroid disease. If it’s the joints, you might have rheumatoid arthritis. Common symptoms of autoimmune disease include fatigue, dizziness, joint pain and swelling, skin problems, digestive issues, fever and swollen glands. Often, patients have more than one autoimmune disorder, Dr. Manzi said.

“These disorders can be difficult to diagnose, and they can be difficult to manage and treat,” Dr. Manzi said.

When patients present with symptoms of autoimmune disease, doctors often test patients’ blood for antinuclear antibodies, a category of antibodies that attack healthy proteins within the cell nucleus. But this test only shows that you might have an autoimmune disease; it can’t tell you which one.

Scientists at AHN’s Autoimmunity Institute and elsewhere are working on better ways to diagnose and monitor patients. Drs. Ahearn and Manzi developed a blood test to help diagnose lupus with greater ease and accuracy. The test, called Avise-SLE, became commercially available in 2012.

Treatments for autoimmune disease continue to evolve as well. In July 2021, the Food and Drug Administration approved the first new drug for lupus in 10 years. Advances in lupus treatment in the past few decades mean patients with the disease are able to live longer, healthier lives. But because lupus can affect various parts of the body, many patients still need more treatment options.

Advertise with us

Researchers at the Autoimmunity Institute are investigating promising new therapies for lupus and several other autoimmune diseases.

“We are now at the steepest trajectory of discovery,” said Dr. Ahearn. “The science is not perfect yet, but we have great tests and we’re getting better at diagnosing patients. This is a time for great optimism among providers and patients.”

A growing crisis

Troublingly, the prevalence of autoimmune disorders seems to be rising. A 2020 study published in the journal Arthritis and Rheumatology found that the presence of antinuclear antibodies, the most common indicator of autoimmunity in the blood, was significantly increasing in the United States overall and particularly among men, non-Hispanic whites, adults 50 years and older and adolescents.

Dr. Manzi said part of the increase in autoimmune disorders is likely due to the fact that doctors are getting better at diagnosing it. But there may be other factors — such as diet, stress and chemicals in the environment — that are pushing numbers upward. Some studies suggest that people living in cities are more susceptible to developing autoimmune diseases due to exposure to various pollutants.

Advertise with us

The COVID-19 pandemic is also shining a light on autoimmunity. Many patients who have been hospitalized due to COVID-19 appear to have an autoimmune response in which the body generates self-attacking antibodies. These so-called autoantibodies may contribute to the symptoms of long COVID, health problems that people experience weeks after initially being infected with the coronavirus.

With more people developing autoimmune disorders, a growing number of patients will need care to manage their symptoms.

“The Allegheny Health Network's Autoimmune Institute is an essential step in closing this diagnosis gap and getting patients the right treatment to halt disease progression and improve quality of life,” said Molly Murray, president and CEO of the Autoimmune Association.

She said AHN’s Autoimmunity Institute is a game-changer for patients with complex cases and those living with multiple autoimmune conditions.

“We hope to see this approach replicated across the U.S. and around the world to ensure undiagnosed and autoimmune patients everywhere have access to this innovative care model,” Ms. Murray said.

Emily Mullin: emullin@post-gazette.com .